Bisker-Leib Vered
SEC CIK 1814093 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | COO | 3.12M | — | $200.7K | 7 | 2021-11-16 | 2024-02-08 |
Most active insiders at CMPX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Anderman Jonathan | GC | $47.2K | — |
| 2 | Lerner Neil | CAO | $28.4K | — |
| 3 | Shin Barry | CFO | — | — |
| 4 | Schuetz Thomas J. | CEO, Dir | — | — |
Bisker-Leib Vered made no open-market trades at CMPX in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-09 | 2024-02-08 | CMPX | Compass Therapeutics, Inc. | Bisker-Leib Vered | CEO, Dir | F - Tax | $1.45 | -49.2K | 3.12M | -2% | -$71.3K | |
| D | 2024-01-10 | 2024-01-09 | CMPX | Compass Therapeutics, Inc. | Bisker-Leib Vered | CEO, Dir | A - Grant | $1.93 | +1.75M | 3.17M | +123% | +$3.38M |
| 2023-11-21 | 2023-11-17 | CMPX | Compass Therapeutics, Inc. | Bisker-Leib Vered | COO | F - Tax | $1.50 | -64.4K | 1.42M | -4% | -$96.6K | |
| D | 2023-02-09 | 2023-02-08 | CMPX | Compass Therapeutics, Inc. | Bisker-Leib Vered | COO | A - Grant | $0.00 | +400.0K | 1.48M | +37% | $0 |
| M | 2022-11-25 | 2022-11-22+ | CMPX | Compass Therapeutics, Inc. | Bisker-Leib Vered | COO | S - Sale | $4.23 | -24.5K | 1.06M | -2% | -$103.7K |
| M | 2022-11-22 | 2022-11-18+ | CMPX | Compass Therapeutics, Inc. | Bisker-Leib Vered | COO | S - Sale | $4.36 | -22.3K | 1.08M | -2% | -$97.0K |
| 2021-11-18 | 2021-11-16 | CMPX | Compass Therapeutics, Inc. | Bisker-Leib Vered | COO | A - Grant | $0.00 | +600.0K | 1.11M | +117% | $0 |
Purchase Sale Sale after option exercise All abbreviations